文献速递糖尿病

遗传风险评分可识别糖尿病肾病高风险人群:一项系统综述

Genetic Risk Scores Identify People at High Risk of Developing Diabetic Kidney Disease: A Systematic Review.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

本系统综述检索MEDLINE、Embase、Web of Science和Cochrane Reviews(2022年6月),纳入15项研究,评估遗传风险评分(GRS)预测1型或2型糖尿病患者发生糖尿病肾病(DKD)的效用。7项研究阳性、5项混合、3项阴性;方法学质量最强的9项研究均报告GRS与至少1项DKD指标关联有统计学意义且结果有利。结论认为GRS有助识别DKD高风险糖尿病患者,需进一步前瞻性研究。

要点

  • 15项研究中7项阳性、5项混合、3项阴性。
  • 方法学质量最强的9项研究均报告GRS与至少1项DKD指标关联有统计学意义且结果有利。
  • 作者认为稳健的GRS可在首次临床接诊时用于糖尿病并发症风险分层,需进一步前瞻性研究。

核心结论

  • 本系统综述提供证据表明GRS可用于识别糖尿病肾病高风险糖尿病患者,需进一步前瞻性研究。

研究设计与样本

  • 系统综述,检索MEDLINE、Embase、Web of Science和Cochrane Reviews(2022年6月),共识别400条引文,最终纳入15项研究。
  • 采用Critical Appraisal Skills Programme清单评价研究方法学质量。

主要发现

  • 15项纳入研究中7项结果阳性、5项结果混合、3项结果阴性。
  • 方法学质量最强的9项研究均报告GRS与至少1项DKD指标关联有统计学意义且结果有利。

临床怎么用

  • 作者认为在实践中稳健的GRS可在首次临床接诊糖尿病患者时用于并发症风险分层。

局限性

  • 需进一步前瞻性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease. Measures to prevent and treat DKD require better identification of patients most at risk. In this systematic review, we summarize the existing evidence of genetic risk scores (GRSs) and their utility for predicting DKD in people with type 1 or type 2 diabetes. EVIDENCE ACQUISITION: We searched MEDLINE, Embase, Web of Science, and Cochrane Reviews in June 2022 to identify all existing and relevant literature. Main data items sought were study design, sample size, population, single nucleotide polymorphisms of interest, DKD-related outcomes, and relevant summary measures of result. The Critical Appraisal Skills Programme checklist was used to evaluate the methodological quality of studies. EVIDENCE SYNTHESIS: We identified 400 citations of which 15 are included in this review. Overall, 7 studies had positive results, 5 had mixed results, and 3 had negative results. Most studies with the strongest methodological quality (n = 9) reported statistically significant and favourable findings of a GRS's association with at least 1 measure of DKD. CONCLUSION: This systematic review presents evidence of the utility of GRSs to identify people with diabetes that are at high risk of developing DKD. In practice, a robust GRS could be used at the first clinical encounter with a person living with diabetes in order to stratify their risk of complications. Further prospective research is needed.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ali AS, Pham C, Morahan G, et al. Genetic Risk Scores Identify People at High Risk of Developing Diabetic Kidney Disease: A Systematic Review. J Clin Endocrinol Metab. 2024. PMID: 38039081. doi:10.1210/clinem/dgad704

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。